Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

A gene mutation causes lanceolate hair in rats by disrupting hair shaft integrity.

Monilethrix involves multiple genes affecting hair structure, including DSG4 mutations.

DHEA reduction may be linked to frontal fibrosing alopecia, but more research is needed.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Psychological stress can worsen skin conditions like psoriasis and acne.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

New biomaterials can improve wound healing by promoting nerve and tissue regeneration.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

The 39th Manfred Donike Workshop discussed methods for detecting misuse of steroids, gene doping, and the complexity of identifying drug residues in urine, highlighting the ongoing efforts to improve global anti-doping work.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Genetic mutations cause various hair diseases, and whole genome sequencing may reveal more about these conditions.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.